君实生物：关于控股股东、实际控制人之一兼董事长增持股份进展公告

Core Viewpoint - The chairman of Junshi Biosciences, Mr. Xiong Jun, plans to increase his stake in the company by at least RMB 100 million over the next 12 months, starting from April 12, 2025, with a minimum of RMB 50 million allocated for A-shares [1] Group 1 - Mr. Xiong Jun has already purchased 100,000 A-shares, representing approximately 0.01% of the company's total share capital, with a total transaction amount of RMB 3.8384 million [1] - The share purchase will be conducted through the Shanghai Stock Exchange and the Hong Kong Stock Exchange, utilizing methods such as centralized bidding and block trading [1] - The increase in shareholding is part of a broader strategy to enhance investor confidence and demonstrate commitment to the company's future [1]